InsiderDB

Lobbying disclosures · Lobbying report

RARE: third_quarter 2026 lobbying report

Issues relating to rare disease and patient access. Issues related to newborn screening. FY27 Appropriations (H.R.8646, Agriculture, Rural Development, Food and Drug Administration)

Follow RARE
Became public
Oct 20, 2026, 11:38 AM EDT
Event / period date
Not stated
Collected
Nov 9, 2026, 7:09 AM EST

Why this is connected

Exact legal-name match: Ultragenyx Pharmaceutical Inc. (https://www.sec.gov/Archives/edgar/data/1515673/).

Reported lobbying amounts

Income: $60,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/6735d81f-5515-4f9d-8998-91a21137d2df/","filing_uuid":"6735d81f-5515-4f9d-8998-91a21137d2df","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/6735d81f-5515-4f9d-8998-91a21137d2df/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Solveig L Monson","dt_posted":"2026-10-20T11:38:59-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1341 G Street, NW","registrant_address_2":"Suite 1100","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":284950,"url":"https://lda.gov/api/v1/registrants/284950/","house_registrant_id":36893,"name":"MEHLMAN CONSULTING, INC.","description":"Government Affairs Consulting Services","address_1":"1341 G Street, NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SOLVEIG MONSON","contact_telephone":"+1 202-585-0292","dt_updated":"2026-10-20T18:04:37.956203-04:00"},"client":{"id":60882,"url":"https://lda.gov/api/v1/clients/60882/","client_id":60882,"name":"ULTRAGENYX PHARMACEUTICAL, INC.","general_description":"Biopharmaceutical Company","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-07-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues relating to rare disease and patient access. Issues related to newborn screening.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY27 Appropriations (H.R.8646, Agriculture, Rural Development, Food and Drug Administration)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":27658,"prefix":null,"prefix_display":null,"first_name":"BRUCE","nickname":null,"middle_name":null,"last_name":"MEHLMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":5659,"prefix":null,"prefix_display":null,"first_name":"DEAN","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":7381,"prefix":"mr","prefix_display":"MR.","first_name":"DAVID","nickname":null,"middle_name":"R","last_name":"THOMAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":11329,"prefix":null,"prefix_display":null,"first_name":"ELISE","nickname":null,"middle_name":null,"last_name":"FINLEY PICKERING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61179,"prefix":null,"prefix_display":null,"first_name":"SAGE","nickname":null,"middle_name":null,"last_name":"EASTMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62201,"prefix":null,"prefix_display":null,"first_name":"LAUREN","nickname":null,"middle_name":null,"last_name":"ARONSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62279,"prefix":null,"prefix_display":null,"first_name":"MICHAEL","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70218,"prefix":null,"prefix_display":null,"first_name":"NICHOLE","nickname":null,"middle_name":null,"last_name":"DISTEFANO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71503,"prefix":null,"prefix_display":null,"first_name":"PAUL","nickname":null,"middle_name":null,"last_name":"THORNELL","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69162,"prefix":null,"prefix_display":null,"first_name":"HELEN","nickname":null,"middle_name":null,"last_name":"TOLAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101897,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":"M.","last_name":"COTE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101395,"prefix":null,"prefix_display":null,"first_name":"ALEXANDER","nickname":null,"middle_name":null,"last_name":"PERKINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101614,"prefix":null,"prefix_display":null,"first_name":"ROSEMARY","nickname":null,"middle_name":null,"last_name":"GUTIERREZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":107920,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"MALLOVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141084,"prefix":null,"prefix_display":null,"first_name":"CAITLIN","nickname":null,"middle_name":null,"last_name":"VAN SANT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141085,"prefix":null,"prefix_display":null,"first_name":"LISA","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":144745,"prefix":null,"prefix_display":null,"first_name":"ALYENE","nickname":null,"middle_name":null,"last_name":"MLINAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145248,"prefix":"ms","prefix_display":"MS.","first_name":"ERICA","nickname":null,"middle_name":"JAY","last_name":"CHABOT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146767,"prefix":null,"prefix_display":null,"first_name":"ANNIE","nickname":null,"middle_name":null,"last_name":"WOLF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147548,"prefix":null,"prefix_display":null,"first_name":"NAVEEN","nickname":null,"middle_name":null,"last_name":"PARMAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149379,"prefix":null,"prefix_display":null,"first_name":"JON","nickname":null,"middle_name":null,"last_name":"ADAME","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":151069,"prefix":"mr","prefix_display":"MR.","first_name":"JOSEPH","nickname":null,"middle_name":"EDWARD","last_name":"BROWN","suffix":"iii","suffix_display":"III"},"covered_position":null,"new":false},{"lobbyist":{"id":152223,"prefix":null,"prefix_display":null,"first_name":"EARL","nickname":null,"middle_name":"SCOTT","last_name":"FLOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":155107,"prefix":null,"prefix_display":null,"first_name":"SEAN","nickname":null,"middle_name":null,"last_name":"BRADY","suffix":null,"suffix_display":null},"covered_position":"Dir Leg Affairs (DOC, Intl Trade Admin); CoS, Dep. CoS/ LD, SLA, LA, Staff Asst (Rep. Vern Buchanan); Intern (Rep. Fred Upton); Intern (Rep. Dan Lungren)","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Price change after we could observe it

+3.47% RARE

Adjusted closing prices from Nov 10, 2026 to Nov 11, 2026. SPY changed 1.32% over the same dates. The start is the first available close after both publication and collection. This is a price comparison, not an executed trade, investor profit, or a backtested strategy.

Congressional trading in RARE

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.